Supplement 4 from Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial

<p>Table S1-S3</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Fei Cao (22247259) (author)
Diğer Yazarlar:	Yan Li (22247262) (author), Qi Fang (22247265) (author), Ruobin Lin (22247268) (author), Zheng Zhao (22247271) (author), Pengfei Xu (22247274) (author), Honghong Yan (22247277) (author), Xinrui Zhang (22247280) (author), Ke Jiang (22247283) (author), Jian Zhou (22247286) (author), Chunyan Chen (22247289) (author), Lixia Lu (22247292) (author), Fei Han (22247295) (author), Zhiming Li (15056927) (author), Di Wu (22247298) (author), Xuekui Liu (22247301) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase II clinical trials Head, Neck & Oral Cancers Immunotherapy Combination immunotherapy
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller